2011 Publications

Carr AD (2011). "eGFR slope and tenofovir nephrotoxicity." J Acquir Immun Defic Syndr 56: 95-96.

Carr AD (2011). "Statins as anti-inflammatory therapy in HIV disease? ." J Infect Dis 203: 751-752.

A.Kurts, M. L. a. (2011). "Patenting of Genes in Australia – A local perspective in light of recent legislative developments." Pathology 43(4): 395-397.

Ammaranond, P., van Bockel, DJ, Petoumenos, K, McMurchie, M, Finlayson, R, Middleton, MG, Davenport, MP, Venturi, V, Suzuki, K, Gelgor, L, Kaldor, JM, Cooper, DA, Kelleher, AD (2011). "HIV Immune Escape at an Immunodominant Epitope in HLA-B*27-Positive Individuals Predicts Viral Load Outcome." J Immunol 186: 479-488.

Arenas-Pinto A, G. A., Bhaskaran K, Copas A, Carr A, Worm SW, Martinez E, Reiss P, Dunn D, Weber R, Hoy J, Weller I (2011). "Lactic Acidosis International Study Group. Risk factors for fatality in HIV-infected patients with dideoxynucleoside-induced severe hyperlactataemia or lactic acidosis." Antiviral Ther 16: 219-226.

Breit SN, C. J., Tsai VWW, Yagoutifam N, Luo W, Kuffner T, Bauskin AR, Wu L, Jiang L, Barany P, Heimburger O, Murikami M, Apple FS, Marquis CP, Macia L, Lin S, Sainsbury A, Herzog H, Law M, Stenvinkel P, Brown DA (2011). "Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end stage renal disease." Nephrol Dial Transplant.

Breit SN, J. H., Cook AD, Tsai VWW, Mohammad MG, Kuffner T, Zhang HP, Marquis CP, Jiang L, Glen Lockwood G, Lee-Ng M, Husaini Y, Wu L, John A Hamilton JA, Brown DA (2011). "The TGF-b superfamily cytokine, MIC-1/GDF15: a pleotrophic cytokine with roles in inflammation, cancer and metabolism." Growth Factors 29: 187-195.

Cysique LA, F. D., Jr., Abramson I, Ellis RJ, Letendre S, Collier A (2011). "Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change." J Clin Exp Neuropsychol 7: 1-18.

Cysique LA, M. P., Bain MP, Wright E, Brew BJ (2011). "HIV and Age Do Not Substantially Interact in HIV-Associated Neurocognitive Impairment." J Neuropsychiatry Clin Neurosci 23(1): 83-89.

David J. van Bockel, D. A. P., Mee Ling Munier, Vanessa Venturi, Tedi E. Asher, Kristin Ladell, Hui-Yee Greenaway, John Zaunders, Daniel C. Douek, David A. Cooper, Miles P. Davenport, Anthony D. Kelleher (2011). "Persistent survival of prevalent clonotypes within an immunodominant HIV Gag-specific CD8+ T-cell response." J Immunol 186(1): 359-371.

Gupta S, V. F., Riggs K, Jin H, Grant I, Cysique L (2011). "Neuropsychological performance in mainland china: the effect of urban/rural residence and self-reported daily academic skill use." J Int Neuropsychol Soc 17(1): 163-173.

John Zaunders, W. B. D. a. M. C. (2011). "The Sydney Blood Bank Cohort: implications for viral fitness as a cause of elite control." Current Opinion in HIV/AIDS 6(3): 151-156.

Loi TH, C. A., Bryant A, Molloy TJ, Lutherborrow M, Turner J, Yang YH, Ma DD.  (2011). "Discriminating lymphomas and reactive lymphadenopathy in lymph node biopsies by gene expression profiling." BMC Med Genomics 4: 27.

M.Lutherborrow, A. B., V.Jayaswal, D.Agapiou, C.Palma, Y.Yang, D.Ma (2011). "Expression profiling of cytogenetically normal AML identifies microRNAs that target genes involved in monocytic differentiation." American Journal of Hematology 86(1): 2-11.

McAllister J, C. A. (2011). "Should a protease inhibitor be standard of care for HIV postexposure prophylaxis?" AIDS 25: 721-722.

McNulty A, C. A. (2011). "Approach to those placing others at risk of HIV infection in NSW." Intern Med J 41: 365.

Mynott AV, H. S., Brown LJ, Breit SN, Kobe B, Curmi PM (2011). "Crystal structure of importin-α bound to a CLIC4 NLS peptide." FEBS J.

Nivison-Smith I, D. A., Dunkley, H, Ma D, Moore J, Simpson M, Szer J, Bradstock K. (2011). "Increased activity and improved outcome in unrelated donor haemopoietic stem cell transplants for acute myeloid leukaemia in Australia, 1992-2005." Internal Medicine Journal 41(1a): 27-34.

Parsi K, E. T., Low J, Fung Ma DD, Joseph JE. (2011). "In vitro effects of detergent sclerosants on clot formation and fibrinolysis." Eur J Vasc Endovasc Surg. 41(2): 267-277.

Phillips W, L. R., Nancarrow DJ, Watson DI, Whiteman DC (2011). "Barretts Oesophagus." J Gastroenterol Hepatol '26: 639-648.

RV, L. (2011). "Does antireflux surgery prevent progression of Barrett's Oesophagus?" Minerva Chirurgica 66(1): 1-6.

Sauce D, L. M., Fastenackels S, Pauchard M, Ait-Mohand H, Schneider L, Guihot A, Boufassa F, Zaunders J, Iguertsira M, Bailey M, Gorochov G, Duvivier C, Carcelain G, Kelleher AD, Simon A, Meyer L, Costagliola D, Deeks SG, Lambotte O, Autran B, Hunt PW, Katlama C, Appay V (2011). "HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis." Blood 117(19): 5142-5151.

Tsai VWW, M. M., Tolhurst O, Breit SN, Sawchenko PE, Brown DA (2011). "CCAAT/enhancer binding protein-δ expression by dendritic cells regulates CNS autoimmune inflammatory disease." J Neurosci.

V.Jayaswal, M. L., D.Ma, Y. Yang (2011). "Identification of microRNA-mRNA Cliques using Microarray Data." BMC Genomics 12: 138.

van Bockel, D. A. P., ML Munier, V Venturi, T E Asher, J Zaunders, D C Douek, D A Cooper, M Davenport and AD Kelleher (2011). "Association of avidity with the persistent survival of dominant clonotypes for an immunodominant HIV-specific CD8+ T-cell response." J Immunol 186(1): 359-371.

Wand H, C. D., Calmy A, Law M, Cooper D, Emery S, Carr A (2011). "Prospective evidence that HIV lipoatrophy and visceral adiposity are partially independent processes." Open Access J Clin Trial 3: 1-7.

2010 Publications


Amin J, Martin A, Bloch M, Carr A. Response to Landmann and Soonawala: the STEAL study. Clin Infect Dis 2010;50:1200-201.

Bauskin AR, Jiang L, Luo XW, Wu L, Brown DA, Breit SN. The TGF-β superfamily cytokine MIC-1/GDF15: Secretory mechanisms facilitate creation of latent stromal stores. J Interferon Cytokine Res 2010;30:389-397.

Bobryshev YV, Lu J, Lord RV. Expression of C1q Complement Component in Barrett's Esophagus and Esophageal Adenocarcinoma. J Gastrointest Surg 2010;14:1207-1213.

Bobryshev YV, Freeman A, Botelho NK, Tran D, Levert-Mignon AJ, Lord RV. Expression of the putative stem cell marker Musashi-1 in Barrett’s esophagus and esophageal adenocarcinoma. Dis Esoph 2010;23:580-589.

Botelho NK, Schneiders FI, Lord SJ, Freeman A, Tyagi S, Nancarrow D, Hayward N, Whiteman D, Lord RV. Gene expression alterations in formalin-fixed, paraffin-embedded Barrett’s esophagus and esophageal adenocarcinoma tissues. Cancer Biol Ther 2010;10(2):172-179.

Braidy N, Grant R, Adams S, Guillemin GJ. Neuroprotective Effects of Naturally Occurring Polyphenols on Quinolinic Acid-Induced Excitotoxicity in Human Neurons. FEBS J 2010;277(2):368-382.

Brockman MA, Brumme ZL, Brumme CJ, Miura T, Sela J, Rosato PC, Kadie CM, Carlson JM, Markle TJ, Streeck H, Kelleher AD, Markowitz M, Jessen H, Rosenberg E, Altfeld M, Harrigan PR, Heckerman D, Walker BD, Allen TM. Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection. J Virol 2010;84(22): 11937-11949.

Calmy A, Bloch M, Wand H, Delhumeau C, Finlayson R, Rafferty M, Norris R, Hirschel B, Cooper DA, Carr A. URISTAT study group. No significant effect of uridine or pravastatin treatment for HIV lipoatrophy in men who have ceased thymidine analogue nucleoside reverse transcriptase inhibitor therapy: a randomized trial. HIV Med 2010;11:493-501.

Campillo-Gimenez L, Laforge M, Fay M, Brussel A, Cumont MC, Monceaux V, Diop O, Lévy Y, Hurtrel B, Zaunders J, Corbeil J, Elbim C, Estaquier J. Nonpathogenesis of simian immunodeficiency virus infection is associated with reduced inflammation and recruitment of plasmacytoid dendritic cells to lymph nodes, not to lack of an interferon type I response, during the acute phase. J Virol 2010;84(4):1838-1846.

Campillo-Gimenez L, Cumont MC, Fay M, Kared H, Monceaux V, Diop O, Müller-Trutwin M, Hurtrel B, Lévy Y, Zaunders J, Dy M, Leite-de-Moraes MC, Elbim C, Estaquier J. AIDS progression is associated with the emergence of IL-17 producing cells early after SIV infection. J Immunol: 2010;184,984-992.

Carr A, Hoy J. Low bone mineral density with tenofovir: does statistically significant mean clinically significant? Clin Infect Dis 2010;51:973-975.

Carr A, Weber R, Sabin C, Reiss P, De Wit S, Worm SW, Law M, Dabis F, Monforte AD, Fontas E, El-Sadr W, Kirk O, Rickenbach M, Phillips A, Ledergerber B, Lundgren JD (D:A:D Study Group). Hepatitis B or C virus co-infections and risk of myocardial infarction in HIV-infected persons. Antiviral Ther 2010;15:1077-1086.

Cherry C, Affandi JS, Brew BJ. Hepatitis C seropositivity is not a risk factor for sensory neuropathy among HIV patients. Neurology 2010;74:1538-1542.

Chen Y, Stankovic R, Cullen K, Meininger V, Coggan S, Garner B, Grant R, Brew BJ, Guillemin GJ. The kynurenine pathway and inflammation in amyotrophic lateral sclerosis. Neurotoxicity Research 2010;18(2):132-142.

Connor DE, Exner T, Ma DD, Joseph JE. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib. Thromb Haemost 2010;103(5):1044-1052.

Cysique LA, Letendre SL, Ake C, Jin H, Franklin DR, Gupta S. Incidence and nature of cognitive decline over 1 year among HIV-infected former plasma donors in China. Aids 2010;24(7):983-990.

Cysique LA, Murray JM, Dunbar M, Jeyakumar V, Brew BJ. A screening algorithm for HIV-associated neurocognitive disorders. HIV Med 2010;11(10):642.

Dunbar M, Murray JM, Cysique LA, Brew BJ, Jeyakumar V. Simultaneous classification and feature selection via convex quadratic programming with application to HIV-associated neurocognitive disorder assessment. European Journal of Operational Research 2010;206:470-478.

Estaquier J, Zaunders JJ. Cytokines and the pathogenesis of HIV infection. Eur Cytokine Network 2010;21(3):195-196.

Falster K, Wand H, Donovan B, Anderson J, Nolan D, Watson K, Watson J, Law MG, on behalf of the Australian HIV Observational Database (Carr A, member). Hospitalisations in a cohort of HIV patients in Australia, 1999-2007. AIDS 2010;24:1329-1339.

Farge D, Labopin M, Tyndall A, Fassas A, Mancardi GL, Van Laar J, Ouyang J, Kozak T, Moore J, Kötter I, Chesnel V, Marmont A, Gratwohl A, Saccardi R. Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for autoimmune diseases: 10 years experience from the European Group for Blood and Marrow Transplantation (EBMT) Working Party on Autoimmune Diseases. Haematologica 2010;95:284-292.

French MA, Tanaskovic S, Law MG, Lim A, Fernandez S, Ward LD, Kelleher AD, Emery S. Vaccine-induced IgG2 anti-HIV p24 is associated with control of HIV in patients with a 'high-affinity' FcgammaRIIa genotype. AIDS 2010;24(13):1983-1990.

Goodchild S, Michael H, Littler D, Mandyam R, Sale K, Mazzanti M, Breit SN, Curmi PM, Brown L. The metamorphic response of the CLIC1 chloride intracellular ion channel protein upon membrane interaction. Biochemistry 2010;49:5278-5289.

Grant R, Nguyen S, Guillemin GJ. Kynurenine pathway metabolism is involved in the maintenance of the intracellular NAD+ concentration in human primary astrocytes. International Journal for Tryptophan Research 2010;3:151-156.

Guillemin GJ. Editorial ISTRY 2010 Special Issue. International Journal for Tryptophan Research 2010;3:49-50.

Hagberg L, Brew BJ, Cinque P, Fuchs D, Gisslén M, Price RW. Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection. AIDS Res Ther 2010;7:15.

Hemachandra A, Puls RL, Sirivichayakul S, Kerr S, Thantiworasit P, Ubolyam S, Cooper DA, Emery S, Phanuphak P, Kelleher AD, Ruxrungtham K on behalf of the Australia Thai HIV Vaccine Consortium. An HIV-1 Clade A/E DNA Prime, Recombinant Fowlpox Virus Boost Vaccine is Safe, but Non-Immunogenic in a Randomized Phase I/IIa Trial in Thai Volunteers at Low Risk of HIV Infection. Hum Vaccine 2010;6(10).

Kanmogne GD, Kuate CT, Cysique LA, Fonsah JY, Eta S, Doh R. HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon. BMC Neurol 2010;10(60): 60.

Koelsch K, Xu Y, Bailey M, McBride K, Seddiki N, Suzuki K, Murray J, Cooper DA, Kelleher AD, Zaunders J. Most HIV DNA in PBMC is present in non-gut homing, resting memory CD4+ T cells with a ß7-CD38-CD127 high phenotype. Journal of the International AIDS Society 2010;13:02.

Li H, Kim WS, Guillemin GJ, Hill A, Evin G, Garner B. Modulation of amyloid precursor protein processing by synthetic ceramide Analogues. Special Issue - Lipids and Alzheimer’s disease 2010;1801:887-895.

Lim CK, Brew BJ, Guillemin GJ. Understanding the roles of the kynurenine pathway in multiple sclerosis progression (Review). International Journal for Tryptophan Research 2010;3:157-167.

Littler DR, Harrop SJ, Goodchild SC, Phang JM, Mynott AV, Jiang L, Valenzuela SM, Mazzanti M, Brown LJ, Breit SN, Curmi PM. The enigma of the CLIC proteins: ion channels, redox proteins, enzymes, scaffolding proteins. FEBS Letters 2010;584:2093-2101.

Lampe FC, Duprez DA, Kuller LH, Tracy R, Otvos J, Stroes E, Cooper DA, Hoy J, Paton, Nick I, Friis-Møller N, Neuhaus J, Liappis AP, Phillips AN, INSIGHT SMART Study Group (Carr A, member). Changes in lipids and lipoprotein particle concentrations after interruption of antiretroviral therapy. J Acquir Immun Defic Syndr 2010;54:275-284.

Littler DR, Brown LJ, Breit SN, Perrakis A, Curmi PM. Structure of human CLIC3 at 2 A resolution. Proteins 78: 2010;1594-1600.

Lutherborrow M, Appavoo M, Simpson A, Tuch B. Gene expression profiling of HuH7-ins: lack of a granulogenic function for Chromogranin A. Islets 2010;1(1):60-72.

Martin A, Amin J, Cooper DA, Carr A, Kelleher AD, Bloch M, Baker D, Woolley I, Emery S, STEAL study group. Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized, clinical trial. AIDS 2010;24:2657-2663.

Martinez E, Visnegarwala F, Grund B, Thomas A, Gibert C, Shlay J, Drummond F, Pearce D, Edwards S, Reiss P, El-Sadr W, Carr A. The effects of intermittent, CD4-guided antiretroviral therapy on body composition and metabolic parameters. AIDS 2010;24:353-363.

Miura T, Brumme ZL, Brockman MA, Rosato P, Sela J, Brumme CJ, Pereyra F, Kaufmann DE, Trocha A, Block BL, Daar ES, Connick E, Jessen H, Kelleher AD, Rosenberg E, Markowitz M, Schafer K, Vaida F, Iwamoto A, Little S, Walker BD. Impaired replication capacity of acute/early viruses in persons who become HIV controllers. J Virol 2010.

Mohamed M. Essa, Amanat AA, Mostafa I. Waly, Guillemin GJ, Subramanian P. Effect of leaves on serum lipids in ammonium chloride induced experimental hyperammonemic rats Pongamia pinnata. Int J Biol Med Res 2010;1(3):71-73.

Nicholas WS. Davies, Guillemin GJ. a. Brew BJ. Tryptophan, Neurodegeneration and HIV-Associated Neurocognitive Disorder (Review). International Journal for Tryptophan Research 2010;3:121-140.

Parsi K, Exner T, Ma DD, Joseph JE. In vitro effects of detergent sclerosants on fibrinolytic enzymes and inhibitors. Thromb Res. 2010;126(4):328-336.

Pett SL, Emery S, Kelleher AD, Cooper DA. Antiretroviral agents: Focus on maraviroc for the treatment of HIV-1-infected adults. Clinical Medicine Insights. Therapeutics 20102:1-17.
Pett SL, Kelleher AD, Emery S. Role of interleukin-2 in patients with HIV infection. Drugs 2010;70(9):1115-1130.

Pett SL, Zaunders J, Bailey M, Murray J, Macrae K, Emery S, Cooper DA, Kelleher AD. A Novel Chemokine-Receptor-5 (CCR5) Blocker, SCH532706, Has Differential Effects on CCR5(+)CD4(+) and CCR5(+)CD8(+) T Cell Numbers in Chronic HIV Infection. AIDS Res Hum Retroviruses 2010;26(6):653-661.

Qiu MR, Jiang L, Matthaei KI, Schoenwaelder SM, Kuffner T, Mangin P, Joseph JE, Low J, Connor D, Valenzuela SM, Curmi PM, Brown LJ, Mahaut-Smith M, Jackson SP, Breit SN (2010). Generation and characterization of mice with null mutation of the chloride intracellular channel 1 gene. Genesis 2010;48:127-136.

Raboud JM, Cooper DA, Carr A, Grinspoon S, Mulligan K, Sutinen J, Rozenbaum W, Cavalcanti RB, Wand H, Costagliola D, Walmsley S, Glitazone. A meta-analysis of six placebo-controlled trials of thiazolidinedione therapy for HIV lipoatrophy. HIV Clin Trial 2010;11:39-50.

Rahman A, Brew BJ, Guillemin GJ. Lead dysregulates serine/threonine protein phosphatases in human neurons. Neurochemical Research 2010;36(2):195-204.

Roth P, Junker M, Tritschler I, Mittelbronn M, Dombrowski Y, Breit SN, Tabatabai G, Wick W, Weller M, Wischhusen J. GDF-15 contributes to proliferation and immune escape of malignant gliomas. Clin Cancer Res 2010;16:3851-3859.

Smith C, Worm S, Friis-Møller N, Sabin CA, Sjøl A, Lundrgen JD, Salbøl-Brandt R, Rickenbach M, Pezzotti P, Krum E, Gras L, Balestre E, Sundström A, Delforge M, Fontas E, Torres F, Petoumenos K, Kjær J, Collins S, Storpher S, Pearce G, Rode R, Weller I study group (Carr A member). Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D study. AIDS 2010;24:1537-1548.

Skipworth RJE, Deans D, Tan BHL, Sangster K, Paterson-Brown S, Brown DA, Hunter M, Breit SN, Ross JA, Fearon KCH. Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer. British Journal of Cancer 2010;102:665-672.

Samaras K, Botelho NK, Chisholm DJ, Lord RV. Subcutaneous and visceral adipose tissue FTO gene expression and adiposity, insulin action, glucose metabolism, and inflammatory adipokines in type 2 diabetes mellitus and in health. Obes Surg 2010;20(1):108-113.

Samaras K, Botelho NK, Chisholm DJ, Lord RV. Subcutaneous and visceral adipose tissue gene expression of serum adipokines that protect type 2 diabetes. Obesity 2010;18(5):884-889.

Samaras K, Richardson R, Carr A (2010). Greater post-prandial LDL cholesterol excursions with low-dose ritonavir than with raltegravir in HIV-uninfected adults: a randomized trial. AIDS 2010;24:1727-1731.

Sasson SC, Smith S, Seddiki N, Zaunders JJ, Bryant A, Koelsch KK, Weatherall C, Munier ML, McGinley C, Yeung J, Mulligan SP, Moore J, Cooper DA, Milliken S, Kelleher AD. IL-7 receptor is expressed on adult pre-B-cell acute lymphoblastic leukemia and other B-cell derived neoplasms and correlates with expression of proliferation and survival markers. Cytokine 2010;50(1): 58-68.

Shen B, Wei A, Whittaker S, Williams LA, Tao H, Ma DD, Diwan AD. The Role of BMP-7 in Chondrogenic and Osteogenic Differentiation of Human Bone Marrow Multipotent Mesenchymal Stromal Cells in vitro. Journal of Cellular Biochemistry 2010;109(2):406-416.

Sinn K, Richardson R, Carr A. Lower arterial stiffness and Framingham score after switching abacavir to tenofovir in men at high cardiovascular risk. AIDS 2010;24: 2403-2405.

Spector SA, Singh KK, Gupta S, Cysique LA, Jin H, Letendre S. APOE epsilon4 and MBL-2 O/O genotypes are associated with neurocognitive impairment in HIV-infected plasma donors. Aids 2010;24(10):1471-1479.

Suzuki K, Kelleher AD. Lessons from viral latency in T cells: manipulating HIV-1 transcription by siRNA. HIV Therapy 2010;4:199-213.

Swaminthan S, Hood C, Suzuki K, Kelleher AD. RNA duplexes in transcriptional regulation. BioMolecular Concepts: 2010;285-296.

Tong WWY, McAllister J, White PA, Kelleher AD, Carr A. Transmission of triple-class, drug-resistant HIV-1 in Australia. Intern Med J 2010;40:657-661.

Vaithilingam V, Brew BJ, Oberholzer J, Guillemin GJ, Tuch BE. Beneficial Effects of Desferrioxamine on Encapsulated Human Islets - In vitro & In vivo study. American Journal of Transplantation 2010;10:1-9.

Viardot A, Lord RV, Samaras K. The Effects of Weight Loss and Gastric Banding on the Innate and Adaptive Immune System in Type 2 Diabetes and Prediabetes. J Clin Endocrinol Metab 2010;95:2845-2850.

Vaithilingam V, Oberholzer J, Guillemin GJ, Tuch BE. The Humanized NOD/SCID Mouse as a Preclinical Model to Study the Fate of Encapsulated Human Islets. Rev Diabet Stud 2010;7(1):56-64.

Wever K, van Agtmael MA, Carr A. Incomplete reversibility of tenofovir-related renal toxicity in HIV-infected men. J Acquir Immun Defic Syndr 2010;55:78-81.

Wiklund FE, Bennet AM, Magnusson PKE, Eriksson UK, Lindmark F, Wu L, Yaghoutyfam N, Marquis CP, Stattin P, Pedersen NL, Adami H-O, Grönberg H, Breit SN, Brown DA. Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality. Aging Cell 2010;9:1057-1064.

Worm SW, Friis-Møller N, Bruyand M, D'Arminio Monforte A, Rickenbach M, Reiss P, El-Sadr W, Phillips A, Lundgren J, Sabin C. High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome. AIDS 2010;24:427-435.

Worm SW, Sabin C, Weber R, Reiss P, El-Sadr W, Dabis F, De Wit S, Law M, Monforte AD, Friis-Møller N, Kirk O, Fontas E, Weller I, Phillips A, Lundgren J. Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study. J Infect Dis 2010;201:318-330.

Wright EJ, Robertson K, Grund B, Brew BJ, Roediger M, Bain MP, Drummond F, Vjecha M, Hoy J, Miller C, de Oliviera A, Pumpradit W, Shlay J, El-Sadr W, Price RW. Cardiovascular risk factors associated with lower baseline cognitive performance in HIV + persons. Neurology 2010;75:864-873.

Yan CS, Hanafi I, Kelleher AD, Carr AD, Amin J, McNally LP, Cunningham PH. Lack of correlation between three commercial platforms for 1 the evaluation of human immunodeficiency virus type 1 (HIV-1) viral load at the clinically critical lower limit of detection. J Clin Virol 2010;49:249-253.

Zhou L, Diefenbach E, Crossett B, Tran SL, Ng T, Rizos H, Rua R, Wang B, Kapur A, Gandhi KG, Brew BJ, Saksena NK. First evidence of overlaps between HIV-Associated Dementia (HAD) and non-viral neurodegenerative diseases: Proteomic analysis of the frontal cortex from HIV+ patients with and without dementia. Molecular Neurodegeneration 2010;5:27.